Back to News
Market Impact: 0.12
Haisco Enters $1.5 Billion Exclusive License Agreement With Sentivera
Source: Nasdaq
Company FundamentalsPatents & Intellectual PropertyPrivate Markets & Venture
Haisco Pharmaceutical Group (002653.SZ) announced an exclusive licensing agreement with Sentivera, a new US venture backed by Population Health Partners and ARCH Venture Partners. No financial terms or commercial milestones were disclosed in the provided text, making the near-term market impact likely limited.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Why is T-Mobile stock tumbling today?
- Why is Verizon stock sliding today?
- SpaceX wants to become a 'major mobile carrier' with low-band spectrum acquisition
- OpenAI projected to bring in $20bn less in revenue than expected
- Soitec climbs 7% as BofA turns bullish on silicon photonics demand
- Schott Pharma drops after Deutsche Bank downgrades on demanding valuation